WASHINGTON — Americans will soon be able to test themselves in the privacy of their own homes for the virus that causes AIDS, now that the Food and Drug Administration has approved the first rapid, over-the-counter HIV test.
The OraQuick test detects the presence of HIV antibodies using a mouth swab and returns a result in 20 to 40 minutes.
Additional Photos
Government officials estimate that about 240,000 people, or one-fifth of the roughly 1.2 million people carrying HIV in the U.S., don’t know they are infected. Testing is a chief means of slowing new infections, which have held steady at about 50,000 per year for two decades.
FDA officials said the test is designed for people who might not otherwise get tested.
“The availability of a home-use HIV test kit provides another option for individuals to get tested so that they can seek medical care, if appropriate,” said Dr. Karen Midthun, director of the FDA’s Center for Biologics Evaluation and Research.
Orasure plans to start selling the test in October, both online and through retailers like Walgreens, CVS and Walmart. It hasn’t set a price yet but expects the consumer version to cost less than $60 but more than the one marketed to health professionals, which costs about $17.50.
CEO Doug Michels said the price increase will help pay for a toll-free call center to provide counseling and medical referrals to test users. “Each of the call-center operators is bilingual in English and Spanish, they’ve gone through 160 hours of training on HIV counseling and testing,” Michels said.
Michels said the company’s marketing efforts will focus on populations at greatest risk of being infected with HIV, including gay and bisexual men, African Americans and Hispanics.
The FDA stressed in its approval announcement that the test is not 100 percent accurate in identifying people with the virus. A trial conducted by test maker Orasure showed that OraQuick detected HIV in those carrying the virus only 92 percent of the time, though it was 99.9 percent accurate in ruling out HIV in patients not carrying the virus.
That means the test could miss one in 12 HIV-infected people who use it but would incorrectly identify only one patient as having HIV for every 5,000 HIV-negative people tested, the FDA said.
People who test negative should be re-tested after three months, because it can take several weeks for detectable antibodies to HIV to appear, according to Dr. Jonathan Mermin, director of the Centers for Disease Control and Prevention’s HIV unit.
HIV awareness groups hailed the approval as an important step in expanding testing for the virus. “This test will allow anyone to empower themselves to know their HIV status when, how and with whom they want to,” said Tom Donohue, founding director of Who’s Positive.
Experts say it’s difficult to predict how widely the test will be used.
According to the Orasure study, 41 percent of people who learned they were HIV-positive using OraQuick had never been tested. The company estimates that 9,000 new HIV carriers would be identified for every 1 million people who use the test.
Test maker Orasure estimates that 9,000 new HIV carriers would be identified for every 1 million people who use the test.
Send questions/comments to the editors.
Success. Please wait for the page to reload. If the page does not reload within 5 seconds, please refresh the page.
Enter your email and password to access comments.
Hi, to comment on stories you must . This profile is in addition to your subscription and website login.
Already have a commenting profile? .
Invalid username/password.
Please check your email to confirm and complete your registration.
Only subscribers are eligible to post comments. Please subscribe or login first for digital access. Here’s why.
Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.